CSE:KETA - Post Discussion
Post by
thelordofstocks on Nov 30, 2021 7:06pm
IPO!
TripSitter's simple yet effective model is capitalizing on the current $16 billion market of anxiety and depression treatment. As psychedelics are slowly becoming more accepted and mainstream as a legitimate anxiety treatment, TripSitter has a business model that makes clients comfortable with this fairly new style. COVID-19 has made telehealth a huge sector, and TripSitter is combining both advanced technology and the emerging psychedelic wellness market to set itself up for a future leading the market. Check out the full story of its IPO here: https://www.streetinsider.com/PRNewswire/TripSitter+To+Commence+Trading+On+Canadian+Securities+Exchange/19280313.html?classic=1
Be the first to comment on this post